Objective: To evaluate the impact of geriatric evaluation in older patients with IBD, reflected in the number and type of (diagnostic and/or interventional) recommendations made, based on a CGA.
ID
Source
Brief title
Condition
- Gastrointestinal inflammatory conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Main study parameters/endpoints: The number and type of (diagnostic and/or
interventional) recommendations, as outcomes of a CGA in older patients with
IBD.
Secondary outcome
To evaluate the number and type of detected geriatric deficits. To evaluate the
impact of disease activity on the type of findings and recommendations, patient
satisfaction and experiences regarding the additional geriatric care, and the
clinical judgement of frailty status by the gastroenterologist and compare it
with the outcomes of the geriatric assessment.
Background summary
Rationale: The number of older patients with Inflammatory Bowel Disease (IBD)
is growing. Previous studies have shown that older patients with IBD have an
increased risk on geriatric syndromes, including multimorbidity, polypharmacy
and frailty. Literature and guidelines emphasize the importance of
multidisciplinary treatment with a geriatrician in (selected) older patients
with IBD. One previous cohort study used a Comprehensive Geriatric Assessment
(CGA) to measure frailty in older patients with IBD and found a high prevalence
of deficits in and frailty in this assessment. The next step is to gain insight
in the diagnostic and/or interventional recommendations that can be made by a
geriatrician based on the deficits that are found in a CGA.
Study objective
Objective: To evaluate the impact of geriatric evaluation in older patients
with IBD, reflected in the number and type of (diagnostic and/or
interventional) recommendations made, based on a CGA.
Study design
Study design: A prospective, single-centre pilot study.
Intervention
The intervention which will performed is a comprehensive geriatric assessment.
Study burden and risks
Nature and extent of the burden and risks associated with participation,
benefit and group relatedness: Patients will be contacted prior to their
outpatient clinic visit by phone. They will be informed about the study, and an
information letter will be sent by mail or post when are interested to
participate. During their regular visit to the outpatient clinic, they will be
asked by their treating physician if they are willing to participate. When they
provide informed consent, they will receive a consultation with a geriatrician
following their regular visit to the outpatient IBD clinic. As the selected
patients are labelled as frail, further evaluation by a geriatrician is
recommended according to current Dutch guidelines and the Spaarne Gasthuis
protocol. Therefore, this geriatric consultation is considered standard of
care. This consultation will take approximately 60 minutes. This consultation
will be considered as baseline. Patients are asked to fill out questionnaires.
After three months questionnaires will be sent by post, as part of normal CGA
procedure.
Boerhaavelaan 22
Haarlem 2035RC
AF
Boerhaavelaan 22
Haarlem 2035RC
AF
Listed location countries
Age
Inclusion criteria
- Diagnosis of Crohn*s disease, Ulcerative Colitis or IBD-unclassified,
confirmed by clinical, endoscopic and/or histologic findings
- Scheduled for an outpatient visit to IBD clinic
- Signed informed consent
- Age >= 65 years
or
- Age >= 60 years with polypharmacy (>= 5 non-IBD medications) and/or significant
comorbidity (score >= 3 Charlson Comorbidity Index (CCI))
Exclusion criteria
- Patients who had a consultation with a geriatrician in the last year
- Patients who are not willing to sign informed consent
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL85343.100.23 |